- call +1-201-465-4211
- email sales@mrinsights.biz
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
Scope of the Report:
This report studies the Genomics Biomarkers market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Genomics Biomarkers market by product type and applications/end industries.
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
The global Genomics Biomarkers market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Genomics Biomarkers.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oncology
Cardiovascular Diseases
Neurological Diseases
Market Segment by Applications, can be divided into
Diagnostic and Research Laboratories
Hospitals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Genomics Biomarkers Market Overview
1.1 Product Overview and Scope of Genomics Biomarkers
1.2 Classification of Genomics Biomarkers by Types
1.2.1 Global Genomics Biomarkers Revenue Comparison by Types (2017-2023)
1.2.2 Global Genomics Biomarkers Revenue Market Share by Types in 2017
1.2.3 Oncology
1.2.4 Cardiovascular Diseases
1.2.5 Neurological Diseases
1.3 Global Genomics Biomarkers Market by Application
1.3.1 Global Genomics Biomarkers Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic and Research Laboratories
1.3.3 Hospitals
1.4 Global Genomics Biomarkers Market by Regions
1.4.1 Global Genomics Biomarkers Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Genomics Biomarkers Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Genomics Biomarkers Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomics Biomarkers Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Genomics Biomarkers Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomics Biomarkers Status and Prospect (2013-2023)
1.5 Global Market Size of Genomics Biomarkers (2013-2023)
2 Manufacturers Profiles
2.1 Roche Diagnostics
2.1.1 Business Overview
2.1.2 Genomics Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Diagnostics Genomics Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.2 Myriad Genetics
2.2.1 Business Overview
2.2.2 Genomics Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Myriad Genetics Genomics Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.3 QIAGEN
2.3.1 Business Overview
2.3.2 Genomics Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 QIAGEN Genomics Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.4 Thermo Fisher Scientific
2.4.1 Business Overview
2.4.2 Genomics Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Scientific Genomics Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bio-Rad Laboratories
2.5.1 Business Overview
2.5.2 Genomics Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bio-Rad Laboratories Genomics Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
3 Global Genomics Biomarkers Market Competition, by Players
3.1 Global Genomics Biomarkers Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Genomics Biomarkers Players Market Share
3.2.2 Top 10 Genomics Biomarkers Players Market Share
3.3 Market Competition Trend
4 Global Genomics Biomarkers Market Size by Regions
4.1 Global Genomics Biomarkers Revenue and Market Share by Regions
4.2 North America Genomics Biomarkers Revenue and Growth Rate (2013-2018)
4.3 Europe Genomics Biomarkers Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Genomics Biomarkers Revenue and Growth Rate (2013-2018)
4.5 South America Genomics Biomarkers Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Genomics Biomarkers Revenue and Growth Rate (2013-2018)
5 North America Genomics Biomarkers Revenue by Countries
5.1 North America Genomics Biomarkers Revenue by Countries (2013-2018)
5.2 USA Genomics Biomarkers Revenue and Growth Rate (2013-2018)
5.3 Canada Genomics Biomarkers Revenue and Growth Rate (2013-2018)
5.4 Mexico Genomics Biomarkers Revenue and Growth Rate (2013-2018)
6 Europe Genomics Biomarkers Revenue by Countries
6.1 Europe Genomics Biomarkers Revenue by Countries (2013-2018)
6.2 Germany Genomics Biomarkers Revenue and Growth Rate (2013-2018)
6.3 UK Genomics Biomarkers Revenue and Growth Rate (2013-2018)
6.4 France Genomics Biomarkers Revenue and Growth Rate (2013-2018)
6.5 Russia Genomics Biomarkers Revenue and Growth Rate (2013-2018)
6.6 Italy Genomics Biomarkers Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Genomics Biomarkers Revenue by Countries
7.1 Asia-Pacific Genomics Biomarkers Revenue by Countries (2013-2018)
7.2 China Genomics Biomarkers Revenue and Growth Rate (2013-2018)
7.3 Japan Genomics Biomarkers Revenue and Growth Rate (2013-2018)
7.4 Korea Genomics Biomarkers Revenue and Growth Rate (2013-2018)
7.5 India Genomics Biomarkers Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Genomics Biomarkers Revenue and Growth Rate (2013-2018)
8 South America Genomics Biomarkers Revenue by Countries
8.1 South America Genomics Biomarkers Revenue by Countries (2013-2018)
8.2 Brazil Genomics Biomarkers Revenue and Growth Rate (2013-2018)
8.3 Argentina Genomics Biomarkers Revenue and Growth Rate (2013-2018)
8.4 Colombia Genomics Biomarkers Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Genomics Biomarkers by Countries
9.1 Middle East and Africa Genomics Biomarkers Revenue by Countries (2013-2018)
9.2 Saudi Arabia Genomics Biomarkers Revenue and Growth Rate (2013-2018)
9.3 UAE Genomics Biomarkers Revenue and Growth Rate (2013-2018)
9.4 Egypt Genomics Biomarkers Revenue and Growth Rate (2013-2018)
9.5 Nigeria Genomics Biomarkers Revenue and Growth Rate (2013-2018)
9.6 South Africa Genomics Biomarkers Revenue and Growth Rate (2013-2018)
10 Global Genomics Biomarkers Market Segment by Type
10.1 Global Genomics Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Global Genomics Biomarkers Market Forecast by Type (2018-2023)
10.3 Oncology Revenue Growth Rate (2013-2023)
10.4 Cardiovascular Diseases Revenue Growth Rate (2013-2023)
10.5 Neurological Diseases Revenue Growth Rate (2013-2023)
11 Global Genomics Biomarkers Market Segment by Application
11.1 Global Genomics Biomarkers Revenue Market Share by Application (2013-2018)
11.2 Genomics Biomarkers Market Forecast by Application (2018-2023)
11.3 Diagnostic and Research Laboratories Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
12 Global Genomics Biomarkers Market Size Forecast (2018-2023)
12.1 Global Genomics Biomarkers Market Size Forecast (2018-2023)
12.2 Global Genomics Biomarkers Market Forecast by Regions (2018-2023)
12.3 North America Genomics Biomarkers Revenue Market Forecast (2018-2023)
12.4 Europe Genomics Biomarkers Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Genomics Biomarkers Revenue Market Forecast (2018-2023)
12.6 South America Genomics Biomarkers Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Genomics Biomarkers Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Genomics Biomarkers Picture
Table Product Specifications of Genomics Biomarkers
Table Global Genomics Biomarkers and Revenue (Million USD) Market Split by Product Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
